BioNTech Results Presentation Deck

Global Social Responsibility at Our Core COVID-19 vaccine pledge to COVAX and the world • 2+ bn doses to low- and middle-income countries by end of 2022 Pandemic response and access to medicines Democratize Access to Novel Medicine Address high medical need diseases such as: Malaria Tuberculosis ● Launched BioNTainers as modular mRNA manufacturing facilities • Establishment of first mRNA manufacturing facility in African Union is expected to start in mid-2022 Introduce drone vaccine delivery in Ghana 10 SBTI, Science Based Targets initiative (in line with Paris agreement) 1 base year: 2021 2 encompasses adhering to ten principles on human rights, the environment and anti-corruption my ¶¶PP Environmental & Climate Protection Climate targets under SBTi Scope 1 & 2: absolute emission reduction of 42% by 20301 ● Responsible Governance Practice good corporate governance and social and societal responsibility Signed UN Global Compact² Attractive Employer Strengthen recruiting and development Diversified employee base from 60+ countries BIONTECH

View entire presentation